We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » AbbVie, Teva Face Pay-for-Delay Lawsuit Over Generic Niaspan
AbbVie, Teva Face Pay-for-Delay Lawsuit Over Generic Niaspan
Brandmaker AbbVie and generics firm Teva are facing a second lawsuit over accusations they illegally delayed generic competition on the cholesterol medication Niaspan.